Lipopolysaccharide-binding protein (LBP) gene polymorphisms: Rapid genotyping by real-time PCR and association with infective endocarditis

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1413-1419

  Vollmer, Tanja ^a   Kleesiek, Knut ^a   Dreier, Jens ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Infective endocarditis; Lipopolysaccharide binding protein; Polymorphism; Real time PCR

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CHEMILUMINESCENT MEASUREMENTS; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; ENDOCARDITIS, BACTERIAL; FEMALE; GENE FREQUENCY; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 69249213450     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.010     Document Type: Article

References (20)

1. Vollmer T., Piper C., Kleesiek K., and Dreier J. Lipopolysaccharide-binding protein: a new biomarker for infectious endocarditis?. Clin. Chem. 55 (2009) 295-304
2. Schumann R.R., and Latz E. Lipopolysaccharide-binding protein. Chem. Immunol. 74 (2000) 42-60
3. Schumann R.R., Rietschel E.T., and Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med. Microbiol. Immunol. 183 (1994) 279-297
4. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., et al. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429-1431
5. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
6. Schumann R.R., Kirschning C.J., Unbehaun A., Aberle H.P., Knope H.P., Lamping N., et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol. Cell. Biol. 16 (1996) 3490-3503
7. Hubacek J.A., Stuber F., Frohlich D., Book M., Wetegrove S., Ritter M., et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit. Care Med. 29 (2001) 557-561
8. Hubacek J.A., Buchler C., Aslanidis C., and Schmitz G. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem. Biophys. Res. Commun. 236 (1997) 427-430
9. Barber R.C., and O'Keefe G.E. Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. Am. J. Respir. Crit. Care Med. 167 (2003) 1316-1320
10. Hubacek J.A., Pitha J., Skodova Z., Adamkova V., Podrapska I., Schmitz G., et al. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction. Clin. Chem. Lab. Med. 40 (2002) 1097-1100
11. Chien J.W., Boeckh M.J., Hansen J.A., and Clark J.G. Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation. Blood 111 (2008) 2462-2469
12. Dreier J., Szabados F., von Herbay A., Kröger T., and Kleesiek K. Tropheryma whipplei infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease. J. Clin. Microbiol. 42 (2004) 4487-4493
13. den Dunnen J.T., and Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum. Genet. 109 (2001) 121-124
14. Korhonen T., Grauling-Halama S., Halama N., Silvennoinen-Kassinen S., Leinonen M., and Saikku P. Rapid genotyping of lipopolysaccharide-binding protein (LBP) C(1341)->T (Leu(436)->Phe) polymorphism by LightCycler real-time PCR. J. Immunol. Methods 317 (2006) 171-174
15. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
16. Zweigner J., Gramm H.J., Singer O.C., Wegscheider K., and Schumann R.R. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98 (2001) 3800-3808
17. Kirschning C.J., Unbehaun A., Fiedler G., Hallatschek W., Lamping N., Pfeil D., et al. The transcriptional activation pattern of lipopolysaccharide binding protein (LBP) involving transcription factors AP-1 and C/EBP beta. Immunobiology 198 (1997) 124-135
18. Zweigner J., Schumann R.R., and Weber J.R. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect. 8 (2006) 946-952
19. Majetschak M., Obertacke U., Schade F.U., Bardenheuer M., Voggenreiter G., Bloemeke B., et al. Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients. Clin. Diagn. Lab. Immunol. 9 (2002) 1205-1211
20. Fang X.M., Schroder S., Hoeft A., and Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit. Care Med. 27 (1999) 1330-1334